The vasodilators market size is expected to see strong growth in the next few years. It will grow to $8.22 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the rising prevalence of hypertension and cardiovascular diseases, growing demand for advanced medical technology for cardiac diseases, the increasing geriatric population worldwide, the rising prevalence of diabetes and high blood pressure, growing importance of personalized medicine. Major trends in the forecast period include strategic mergers and acquisitions, the shift towards outpatient settings and home-based care, product innovations, technological advancements, and expansion of healthcare infrastructure.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/vasodilators-global-market-report
Scope Of Vasodilators Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Vasodilators Market Overview
Market Drivers –
The rising prevalence of cardiovascular diseases is expected to propel the growth of the vasodilators market going forward. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, and stroke, often linked to hypertension and other risk factors. The increasing prevalence of cardiovascular diseases is primarily driven by sedentary lifestyles, poor dietary habits, obesity, tobacco use, and aging populations. Vasodilators are used in cardiovascular diseases to relax blood vessels, reduce blood pressure, and improve blood flow. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a US-based public agency, coronary artery disease (CAD) was responsible for killing 375,476 people in 2021, and about 1 in 20 adults age 20 and older had CAD. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the vasodilators market.
Market Trends –
Major companies operating in the vasodilators market are focusing on developing advanced products, such as soluble guanylate cyclase (sGC) stimulators, to gain a competitive edge in the market. Soluble guanylate cyclase (sGC) refers to an enzyme found in cells, particularly in smooth muscle cells lining blood vessels. When activated, soluble guanylate cyclase (sGC) converts guanosine triphosphate (GTP) into cyclic guanosine monophosphate (cGMP), leading to vasodilation and increased blood flow. For instance, in September 2022, Bayer AG, a Germany-based pharmaceutical and biotechnology company, launched Vericiguat (Verquvo), a soluble guanylate cyclase (sGC) stimulator for adults with symptomatic chronic heart failure. The drug targets a pathway not currently targeted by existing treatments, reducing the risk of cardiovascular death and hospitalization.
The vasodilators market covered in this report is segmented –
1) By Type: Arterial Dilators, Venous Dilators, Mixed Dilators
2) By Drugs: Nitroglycerin, Alprostadil, Minoxidil, Sorbitrate, Other Drugs
3) By Indication: Hypertension, Angina, Heart Failure, Other Indications
4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
5) By End User: Hospitals, Homecare, Speciality Centres, Other End Users
Get an inside scoop of the vasodilators market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16565&type=smp
Regional Insights –
North America was the largest region in the vasodilators market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vasodilators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the vasodilators market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline Plc., Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc. , AstraZeneca, Mayo Foundation for Medical Education and Research (MFMER), Boehringer Ingelheim International GmbH, Bayer AG, Viatris Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen
Table of Contents
1. Executive Summary
2. Vasodilators Market Report Structure
3. Vasodilators Market Trends And Strategies
4. Vasodilators Market – Macro Economic Scenario
5. Vasodilators Market Size And Growth
…..
27. Vasodilators Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Read Related Topics:
https://goodprnews.com/low-molecular-weight-heparin-market-size/
https://goodprnews.com/molecular-spectroscopy-market-size/
https://goodprnews.com/oyster-sauces-market-size/
https://topprnews.com/low-molecular-weight-heparin-market-share/
https://topprnews.com/molecular-spectroscopy-market-share/
https://topprnews.com/oyster-sauces-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
